Asymchem Laboratories (6821.HK) Vs Pharmaron Beijing (3759.HK) - Deep Dive the Logic and the Outlook
⬇ $Asymchem Laboratories(06821)$ - The different business nature of CRO and CDMO leads to different investment logic/outlook for Pharmaron and Asymchem. So, the current performance/valuation divergence between the two is only temporary
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/asymchem-laboratories-6821-hk-vs-pharmaron-beijing-3759-hk-deep-dive-the-logic-and-the-outlook?utm_source=tiger_community
By Xinyao (Criss) Wang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/xinyao-criss-wang?utm_source=tiger_community
On Asymchem Laboratories (06821):- https://www.smartkarma.com/entities/asymchem-laboratories?utm_source=tiger_community
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
